期刊文献+

化疗联合中药治疗在结直肠癌术后的临床效果观察 被引量:9

Clinical effect observation of chemotherapy combined with Chinese herbs treatment after colorectal cancer surgery
下载PDF
导出
摘要 目的观察化疗联合中药治疗在结直肠癌术后的临床效果。方法 2012年9月-2014年9月,将60例结直肠癌术后患者随机分为两组,中药组(30例)采用FOLFOX6化疗方案联合中药,对照组(30例)单纯FOLFOX6化疗方案。比较两组的中医证候疗效、中医症状积分、不良反应情况、血清癌胚抗原(CEA)和T细胞亚群。结果中药组、对照组的中医证候疗效总有效率分别为70.00%、26.67%,两组比较,差异有统计学意义(P〈0.05);两组治疗后的中医症状积分分别为(8.36±3.81)、(15.40±4.90)分,两组比较,差异有统计学意义(P〈0.05)。两组不良反应发生情况的比较:中药组治疗后的RBC、PLT水平显著高于对照组(P〈0.05);中药组治疗后的ALT、AST水平显著低于对照组(P〈0.05);两组的消化道毒性和神经毒性反应情况差异有统计学意义(P〈0.05)。中药组治疗后的CD4+较对照组明显升高,CD8+明显减低(P〈0.05)。结论结直肠癌术后化疗联合中药可以有效改善化疗引起的不良反应(骨髓抑制、消化道毒性和神经毒性反应),提高免疫力。 Objective To observe the clinical effect of chemotherapy combined with Chinese herbs treatment after col-orectal cancer surgery. Methods From Septemper 2012 to Septemper 2014,60 patients undergone colorectal cancer surgery were evenly divided into two groups,Chinese medicinal group (combination of FOLFOX6 chemotherapy regimen combined with Chinese herbs) and control group (only FOLFOX6 chemotherapy regimen).The curative effect of TCM syndrome,TCM symptom score,adverse reaction,serum carcino-embryonic antigen (CEA) and T cell subset between two groups was compared respectively. Results The total effective rate of TCM syndrome in Chinese medicinal group and control group was 70.00%and 26.67%respectively,and there was a statistical difference between two groups (P〈0.05).The TCM symptom score in two groups after treatment was (8.36±3.81) points and (15.40±4.90) points,and there was a sta-tistical difference between two groups (P〈0.05).Comparision of adverse reaction between two groups:RBC,PLT level after treatment in Chinese medicinal group was obviously higher than that of control group respectively (P〈0.05);ALT,AST lev-el after treatment in Chinese medicinal group was obviously lower than that of control group respectively (P〈0.05);there was a statistical difference of gastrointestinal toxicity and neurotoxicity response between two groups (P〈0.05).CD4+was obviously increased while CD8+was obviously decreased after treatment in Chinese medicinal group compared with con-trol group (P〈0.05). Conclusion After colorectal cancer surgery,chemotherapy combined with Chinese herbs can effec-tively improve adverse reaction induded by chemotherapy (myelosuppression,gastrointestinal toxicity and neurotoxicity response) and immunity.
作者 张超 韩振国
出处 《中国当代医药》 2015年第14期135-138,141,共5页 China Modern Medicine
关键词 化疗 中医中药 结直肠癌 Chemotherapy Traditional Chinese medicine Colorectal cancer
  • 相关文献

参考文献19

  • 1董志伟 谷铣之.临床肿瘤学[M].北京:人民卫生出版社,2003.3-470.
  • 2Chinese Anti-cancer Association.New criteria for diagno- sis and treatment of common malignant tumors (fasicle of colorectal cancer)[M].Beijing:Peking Union Medical Col- lege Press, 1999 : 117-139.
  • 3郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2000.299-300.
  • 4Ferlay J,Autier P,Boniol M,et a/,Estimates of the cancer incidence and mortality in Europe in 2006[J].Ann Oncol, 2007,18(3) :581-592.
  • 5Jemal A, Siegel R,Ward E,et d.Cancer statistics, 2009[J]. CA Cancer J Clin, 2009,59(4) : 225-249.
  • 6吴菲,林国桢,张晋昕.我国恶性肿瘤发病现状及趋势[J].中国肿瘤,2012,21(2):81-85. 被引量:375
  • 7American Cancer Society.Cancer Facts & Figures 2009[M]. Atlanta: American Cancer Society, 2009 : 12-13.
  • 8Simmonds PC.Palliative chemotherapy for advanced colorec- tal cancer:systematic review and meta-analysis.Colorectal Cancer collaborative Group[J].BMJ,2006,321 (7260) : 531- 533.
  • 9Litle VR,Warren RS,Moore D,et o].Molecular cytoge- netic analysis of cytokeratin 20-labeled ceils in primary tumors and bone marrow aspirates from colorectal carci- noma patients[J].Cancer, 1997,79(9) : 1664-1670.
  • 10Falcone A, Masi G, Brunetti I,et al.The triplet combina- tion of in',notecan,oxalipplatinand 5FUILV(FOLFOXIRI)vs the doublet of irinotecan maC[ ~FU/eV,(FOLFIRI) as first- line treatment of metastatic colorectal cancer (MCRC): results of a randomized phase Ill trial by the Gruppo On- cologico Nord Ovest(G.O.N.O.)[J].J Clin 0ncol,2006,24 (18S) :3513.

二级参考文献98

共引文献621

同被引文献233

引证文献9

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部